Johnson & Johnson MedTech Announces Completion of First Cases with OTTAVA™ Robotic Surgical System
First use in gastric bypass at Memorial Hermann-Texas Medical Center
Trial will support submission for multiple procedures
NEW BRUNSWICK, N.J., April 14, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in surgical technologies and solutions, today announced completion of the first cases in the clinical trial for the OTTAVA™ Robotic Surgical System. The cases mark the first clinical experience with the OTTAVA System.
Dr. Erik Wilson*, Chief of Minimally Invasive and Elective General Surgery UT Health Houston and the lead investigator for the clinical study, performed Roux-en-Y gastric bypass surgery using the OTTAVA Robotic Surgical System at Memorial Hermann-Texas Medical Center.
'Surgical robotics is at the forefront of innovation in minimally invasive surgery,' Dr. Wilson said. 'I am proud to have performed the first clinical study cases with OTTAVA and potentially help advance the standard in surgical robotics.'
OTTAVA is designed as a multi-specialty soft-tissue surgery robot, supporting a broad range of procedures across patient anatomy and surgical specialties, including the most complex surgeries that require a multi-quadrant approach.
Data from this investigation aims to support the system's ability to perform a variety of procedures. Upon completion of the study, the company plans to submit the OTTAVA system for De Novo authorization in the United States, targeting an indication covering multiple procedures in general surgery within the upper abdomen, such as gastric bypass, gastric sleeve, small bowel resection and hiatal hernia repair.
'We are proud to reach this important milestone in our robotic surgery program,' said Hani Abouhalka, Company Group Chairman, Surgery, Johnson & Johnson MedTech. 'OTTAVA is a key innovation in our portfolio of advanced surgical technologies – all of which are designed to transform the surgical experiences across all surgery. Our people work side-by-side with surgical teams in ORs around the world every day to raise the standard of care for patients and deliver what's next in surgery.'
Johnson & Johnson MedTech's OTTAVA system received investigational device exemption (IDE) approval from the U.S. FDA in late 2024. The system is designed to advance clinical innovation in general surgery, a stronghold for Johnson & Johnson MedTech's broader surgery business. OTTAVA is designed to address unmet needs that persist in robotic surgery today and support complex procedures. The system's unique unified architecture, surgical instrumentation powered by Ethicon expertise, and future connection to the Polyphonic™ digital ecosystem are designed to meet the needs of each patient's care and each surgeon's clinical approach.
'As a company operating at the intersection of biology and technology, clinical evidence generation is the core of our innovation programs to advance surgical technology for patients,' said Peter Schulam M.D., PhD, Chief Scientific Officer, Johnson & Johnson MedTech. 'Through this clinical study, we are proud to be partnering with surgeons to gather evidence and support the ongoing pursuit of scientific study for the advancement of robotic-assisted minimally invasive surgery.'
The OTTAVA robotic system is under development and is not authorized to be marketed or sold in any market. For more information, visit: http://thenext.jnjmedtech.com/surgical-robotics.
Surgical Solutions from Johnson & Johnson MedTech
Across Johnson & Johnson, we are tackling the world's most complex and pervasive health challenges. For over 100 years, we have helped advance surgical care through our innovative portfolio across wound closure, adjunctive hemostats, surgical stapling and instruments, robotics and digital solutions. Together, with clinicians and healthcare experts around the world we are progressing what's next in surgery to better solve patient needs in metabolic and cardiovascular disease, cancer, and aesthetics and reconstruction.
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more about our MedTech sector's global scale and deep expertise in cardiovascular, orthopedics, surgery and vision solutions at https://thenext.jnjmedtech.com. Follow us at @JNJMedTech and on LinkedIn. Auris Health, Inc. is part of Johnson & Johnson MedTech.
*Dr. Wilson is a paid consultant for Johnson & Johnson MedTech.
NOTE TO INVESTORS CONCERNING FORWARD-LOOKING STATEMENTS:
This press release contains 'forward-looking statements' as defined in the Private Securities Litigation Reform Act of 1995 regarding the OTTAVA™ Robotic Surgical System. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to competition, including technological advances, new products and patents attained by competitors; challenges inherent in new product research and development, including uncertainty of clinical success and obtaining regulatory approvals; uncertainty of commercial success for new and existing products; challenges to patents; the impact of patent expirations; manufacturing difficulties or delays, internally or within the supply chain; product efficacy or safety concerns resulting in product recalls or regulatory action; significant adverse litigation or government action, including related to product liability claims; changes to applicable laws and regulations; trends toward health care cost containment; changes in behavior and spending patterns of purchasers of health care products and services. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's most recent Annual Report on Form 10-K, including in the sections captioned 'Cautionary Note Regarding Forward-Looking Statements' and 'Item 1A. Risk Factors,' and in Johnson & Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Any forward-looking statement made in this release speaks only as of the date of this release. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments.
© Johnson & Johnson and its affiliates 2025. US_SRG_RADS_399335
Media contact:
Lindsey Diaz-MacInnis
[email protected]
Investor Relations:
Tracy Menkowski
[email protected]
View original content to download multimedia: https://www.prnewswire.com/news-releases/johnson--johnson-medtech-announces-completion-of-first-cases-with-ottava-robotic-surgical-system-302427207.html
SOURCE Johnson & Johnson MedTech
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
MMA INNOVATE VIETNAM 2025: Important Marketing Event for Vietnam Martech Ecosystem
HO CHI MINH CITY, Vietnam, June 11, 2025 /PRNewswire/ -- MMA INNOVATE VIETNAM, the country's pioneering platform shaping the future of marketing, is back on 21 August 2025 — bigger, bolder, and brimming with opportunities to connect, collaborate, and co-create the next wave of digital transformation. The Vietnam MarTech Report 2024 shows just how quickly the space is evolving: the number of MarTech companies has skyrocketed from 15–20 players in 2023 to nearly 100 in 2024. Furthermore, the KPMG 2024 Customer Experience Excellence Report which highlights how Vietnamese businesses are already leveraging AI to elevate trust, security, and emotional connection — and you've got the perfect storm for innovation. Thus, INNOVATE 2025's theme, "Shaping Growth Through Marketing Insight, Impact, and Innovation," is more than a slogan. It's a call to action for top brands, ambitious SMEs, startups, and marketers to come together and thrive in the age of AI, MarTech, and experience-driven landscape of AI, MarTech, and customer experience. Impressive Numbers from MMA INNOVATE VIETNAM 2024 2,500+ delegates from all corners of the marketing industry Over 30 exhibition booths featuring major names like Samsung, Heineken, Coca-Cola, Nestlé, Unilever, Suntory PepsiCo, AIA, AdFlex, Ecomobi, Haravan, AnyMind, MGID, VCCorp, VietGuys, Chicilon Media, Novaon, Ureka Media, Appier, and many more. 62 speakers from multi-nation corps delivering global insights 25,000+ live views via MMA's social channels and media partners 20 million+ total reach across online and offline platforms Over 300 B2B connections made directly at the event. "MMA INNOVATE VIETNAM 2025 is not just an event – it's a launchpad for businesses to thrive. We believe AI and MarTech are the keys to creating meaningful differentiation for sustainable growth. MMA Global Vietnam is committed to supporting the business community, helping them seize opportunities, overcome challenges, and accelerate in the digital era." – Ms. Phan Bich Tam, Country Director, MMA Global Vietnam. Who Should Exhibit? Businesses and startups in marketing, MarTech, advertising, media, data, AI, and e-commerce. Providers of digital transformation solutions, technology platforms, and creative services. Brands looking to launch new products/services and seeking strategic partners. Book Your Booth Don't miss the chance to connect and grow your business at MMA INNOVATE VIETNAM 2025! Contact the organizing team via email: 0937 811 381Limited booths available – Book early to secure the best spots! PR Newswire is the official Media Partner of the MMA INNOVATE VIETNAM 2025. View original content to download multimedia: SOURCE MMA Vietnam Sign in to access your portfolio
Yahoo
33 minutes ago
- Yahoo
Kanazawa University research: High-speed AFM and 3D modelling help towards understanding the dynamics of a protein implicated in several cancers
KANAZAWA, Japan, June 11, 2025 /PRNewswire/ -- Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University observe and model how the enzyme ADAR1 interacts with double-stranded RNA, which may be useful for future cancer treatment strategies. An enzyme type noted in several cancers is the family of adenosine deaminases acting on RNA (ADARs). These enzymes convert adenosines in double-stranded RNA (dsRNA) into inosines, which cells read as guanosines. As such, ADARs can contribute to changes in protein-coding sequences and diminish the robustness of various RNA processes. Studies have shown that silencing one type of ADAR – ADAR1 – can prevent cancer proliferation and sensitize cancers to immunotherapy, suggesting that they could be a promising target for cancer treatments. However, so far, it has been difficult to pin down information on the structural dynamics of ADAR1 due to its size and complexity. Now, researchers led by Madhu Biyani at Kanazawa University, WPI-NanoLSI, Yasuhiro Isogai at Toyama Prefectural University, and Manish Biyani at Ishikawa Create Labo and Kwansei Gakuin University have combined high-speed atomic force microscopy (HS-AFM) and 3D modelling to shed light on the enzyme's conformations and interactions with dsRNA. Like many proteins, ADAR1 functions through changes in its conformation. However, most experimental techniques for determining protein structure, as well as 3D modelling algorithms, give static or average conformations that obscure the structural dynamics so important to the protein's function. Combining 3D modelling with HS-AFM proved helpful in shedding light on these dynamic aspects of ADAR1. The researchers first used 3D modelling based on the machine learning algorithm AlphaFold2 to predict the conformations of the enzyme and noted that it could take the form of monomers, dimers, trimers, and tetramers. HS AFM observations, as well as theoretically simulated HS AFM, supported these initial conclusions regarding the possible oligomer formations. The researchers then looked at the conformations the enzyme formed in the presence of double-stranded RNA (dsRNA). In particular, the researchers focused on a certain aryl hydrocarbon receptor 3'UTR mRNA as the target for ADAR1, since this receptor is known to be involved in the metabolism of substances alien to the body at those points. Observations of the dsRNA with HS-AFM not only agreed with previous structural studies but were able to provide insights into the structure of the target region in particular. Thanks to the speed and resolution of the HS-AFM image capture, the researchers were able to identify different conformations in the proteins that seemed to relate to distinct phases of the deaminizing process. In their report of the work, the researchers explain how ADAR1 first "searches" for the dsRNA and on "recognizing" it, adopts a flexible conformation as it approaches. The enzyme then engages in what the researchers describe as "capture" of the dsRNA backbone, for which the conformation transitions to something more stable and "anchor-like". The researchers highlight the role of dsRNA binding domains (dsRBDs) to stabilize the interaction with the dsRNA at this stage. They also note "a visibly large interfacial interaction between the deaminase domains, forming a dimer" as the enzyme dimer loops out on the dsRNA. The enzyme subsequently scans the RNA and dissociates to search for adenosine sites to convert. "These observations suggest that the dsRBDs are critical for initiating interactions between the deaminase domains, thereby promoting the formation of a stable, functional dimeric complex capable of efficiently binding and catalyzing the editing of dsRNA substrates," the researchers conclude in their report, thereby flagging the insights this study offers for further work towards possible cancer therapeutics. The researchers further propose future studies to compare ADAR1 and ADAR2, and to perform mutation analyses to clarify how ADAR1 dimerization influences A-to-I RNA editing, ultimately aiming to develop effective ADAR1 inhibitors. Figure 1: Three-dimensional modeling analysis of ADAR1 2025 Biyani, et al., Nature Communications Figure 2: Simulated AFM images of ADAR1 2025 Biyani, et al., Nature Communications Glossary Atomic force microscopy This imaging technique uses a nanosized tip at the end of a cantilever that is scanned over a sample. It can be used to determine the topography of a sample surface from the change in the strength of forces between the tip and the sample with distance, and the resulting deflection of the cantilever. It was first developed in the 1980s, but a number of modifications have augmented the functionality of the technique since. It is better suited to imaging biological samples than the scanning tunnelling microscope that had been previously developed because it does not require a conducting sample. In the 2000s, Toshio Ando at Kanazawa University was able to improve the scanning speed to such an extent that moving images could be captured. This allowed people to use the technique to visualize dynamic molecular processes for the first time. ADARs Adenosine deaminases acting on RNA (ADARs) convert adenosine to inosine, which is interpreted by cells as guanosine. This editing can influence alternative splicing, miRNA processing, double-stranded RNA stability, and protein-coding sequences. In mammals, there are two known ADARs responsible for adenosine to inosine RNA editing – ADAR1 and ADAR2. Notably, overexpression and increased activity of ADAR1 have been observed in cancers of the liver, breast, esophagus, prostate, and bone marrow. 3D modelling Several techniques are now available for protein structure prediction. In this study, the researchers used AlphaFold2 to model the structure of human ADAR1. Due to disorder regions in the N-terminal 822 residues, the final model focused on residues 823-1226, which encompass the deaminase domain. This monomer model served as the basis for building higher-order structures—dimer, trimer, tetramer, and polymer by superimposing it onto the ADAR2 dimer structure (PDB ID:1ZY7) through sequence alignment. Since determining ADAR1's full structure is challenging due to its size and complexity, the better-characterized ADAR2 provided a template to generate ADAR1 multimer models. Reference Madhu Biyani, Yasuhiro Isogai, Kirti Sharma, Shoei Maeda, Hinako Akashi, Yui Sugai, Masataka Nakano, Noriyuki Kodera, Manish Biyani, Miki Nakajima, High-speed atomic force microscopy and 3D modeling reveal the structural dynamics of ADAR1 complexes, Nature Communications 16, 4757 (2025). DOI：10.1038/s41467-025-59987-6 URL: Funding and AcknowledgementsFinancial support from the Grants-in-Aid for Scientific Research (C), KAKENHI, Japan Society for the Promotion of Science (JSPS) (23K06067 to MadhuB), and the World Premier International Research Center Initiative (WPI), MEXT, Japan, are gratefully acknowledged. The authors thank Prof. Toshio Ando, Dr. Kenichi Umeda, Ms. Wei Weilin, Ms. Aimi Makino, and Ms. Kayo Nagatani for their technical support of HS-AFM experiments. Contact Kimie Nishimura (Ms)Project Planning and Outreach, NanoLSI Administration OfficeNano Life Science Institute, Kanazawa UniversityEmail: nanolsi-office@ Kanazawa 920-1192, Japan About Nano Life Science Institute (WPI-NanoLSI), Kanazawa UniversityUnderstanding nanoscale mechanisms of life phenomena by exploring "uncharted nano-realms". Cells are the basic units of almost all life forms. We are developing nanoprobe technologies that allow direct imaging, analysis, and manipulation of the behavior and dynamics of important macromolecules in living organisms, such as proteins and nucleic acids, at the surface and interior of cells. We aim at acquiring a fundamental understanding of the various life phenomena at the About the World Premier International Research Center Initiative (WPI)The WPI program was launched in 2007 by Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT) to foster globally visible research centers boasting the highest standards and outstanding research environments. Numbering more than a dozen and operating at institutions throughout the country, these centers are given a high degree of autonomy, allowing them to engage in innovative modes of management and research. The program is administered by the Japan Society for the Promotion of Science (JSPS). See the latest research news from the centers at the WPI News Portal: WPI program site: About Kanazawa UniversityAs the leading comprehensive university on the Sea of Japan coast, Kanazawa University has contributed greatly to higher education and academic research in Japan since it was founded in 1949. The University has three colleges and 17 schools offering courses in subjects that include medicine, computer engineering, and humanities. The University is located on the coast of the Sea of Japan in Kanazawa, a city rich in history and culture. The city of Kanazawa has a highly respected intellectual profile since the time of the fiefdom (1598-1867). Kanazawa University is divided into two main campuses: Kakuma and Takaramachi for its approximately 10,200 students, including 600 from View original content: SOURCE Kanazawa University
Yahoo
an hour ago
- Yahoo
Advanced Ceramics Market worth $16.27 billion by 2029, at 6.0%, says MarketsandMarkets™
Delray Beach, FL, June 11, 2025 (GLOBE NEWSWIRE) -- In terms of value, the Advanced Ceramics Market is projected to reach USD 16.27 billion by 2029 from USD 12.16 billion in 2024, at a CAGR of 6.0%, as per the recent study by MarketsandMarkets™. The advanced ceramics market has grown robustly over the past few years due to numerous important factors. One of them is rising demand from industries such as electronics, automotive, aerospace, and the healthcare sector, which has given impetus to the growth of this market. Advanced ceramics, with their outstanding characteristics such as high-temperature resistance, strength, and electrical insulation, play a crucial role in producing components like semiconductors, engine components, and medical implants. For example, growth in electric cars and clean technologies has increased demand for ceramics used in batteries and power systems. Technological developments have played a key role to increase performance capabilities, such as corrosion resistance and strength of advanced ceramics, which qualify them for next-generation applications including 5G base stations and space missions. Download PDF Brochure: Browse in-depth TOC on 'Advanced Ceramics Market' 215 - Market Data Tables 54 – Figures 270 - Pages List of Key Players in Advanced Ceramics Market: KYOCERA Corporation (Japan) CeramTec (Germany) CoorsTek (US) Morgan Advanced Materials (UK) 3M (US), AGC Ceramics Co., Ltd. (Japan) MARUWA Co., Ltd. (Japan) Saint-Gobain Performance Ceramics & Refractories (France) Paul Rauschert GmbH & Co. KG. (Germany) Drivers, Opportunities and Challenges in Advanced Ceramics Market: Drivers: Government investments in research, energy, and aerospace & defense industries Restraint: Complex manufacturing processes of advanced ceramics Opportunity: Integration of nanotechnology in advanced ceramic materials Challenge: Brittleness of advanced ceramics Get Sample Pages: Key Findings of the Study: Alumina is projected to have the largest market share in 2024 in terms of value. Ceramic coatings application segment to have the second highest market share in the advanced ceramics market. Asia Pacific to be the largest market during the forecast period. Alumina ceramics has the largest share in terms of material in the advanced ceramics market. Alumina-based ceramics dominate most industrial segments like electronics, aerospace, and medical instruments. Due to their tolerance towards ultra-high temperature, alumina-based ceramics can effectively act as cutters, insulators, and substrates used in manufacturing semiconductor devices. The market for alumina ceramics has increased with the increasing demand for high-performance, long-lasting materials in miniaturized electronics and energy-efficient systems. With industries striving for sustainability, alumina ceramics also play their part by allowing longer-lasting components that minimize waste. In the advanced ceramics industry, their cost-effectiveness and versatility over other high-performance materials have made them a go-to option. Advancements in processing methods, including additive manufacturing, have further diversified their applications and enabled complex geometries and bespoke solutions. The market impact of alumina ceramics is reflected in their predicted growth, stimulated by growing investment in green energy and emerging manufacturing technologies. Ceramic matrix composites (CMCs) is a well-knowned applications in the advanced ceramics market, fueled by their superior properties and increasing uses in high-performance industries. In contrast to conventional ceramics, CMCs integrate ceramic fibers with a ceramic matrix, creating materials that possess greater strength, thermal resistance, and toughness while being lightweight. These properties make them more and more valuable in aerospace, automotive, and energy, where high tolerance to harsh environments is essential. In aerospace alone, for example, CMCs are changing engine parts with the ability to withstand temperatures well above 1,500°C, increasing fuel efficiency, and lowering emissions. This has fuelled demand and made CMCs a critical secondary keyword to the advanced ceramics market. The impact of CMCs on the market is significant since they overcome limitations of traditional materials such as metals and monolithic ceramics. Their thermal shock and wear resistance have increased their application in gas turbines, heat exchangers, and even medical implants, widening the application of the advanced ceramics market. Producers are spending big on research and development to maximize production processes, including chemical vapor infiltration and polymer infiltration pyrolysis, to increase output and lower costs. Get Customization on this Report: Europe commands the third-largest market share among the global advanced ceramics market on account of a mix of industrial strengths, technological capabilities, and multifarious applications across target sectors. The continent's resilient manufacturing sector, more so in nations such as Germany, France, and the UK, underpins strong demand for advanced ceramics. Germany has globally recognized automotive sector, which depends greatly on these materials for parts such as brakes, engine components, and exhaust systems because of their resistance to wear and heat. This industrial dominance is matched by Europe's dominance in aerospace and defense, where high-tech ceramics are valued for their lightness and resistance to harsh conditions, enabling innovations in aircraft and military hardware. Moreover, the emphasis of Europe on sustainability and renewable energy sources supports the market. Advanced ceramics are a central component in the generation of energy, for instance, in solar panels and wind turbines, that is consistent with the region's ambitious environmental agendas. Browse Adjacent Markets Ceramics and Glass Market Research Reports Related Reports: Sodium Silicate Market Gold Nanoparticles Market Advanced Ceramics Market Cyclic Olefin Polymer Market Heavy Construction Equipment Market CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email: sales@ Visit Our Website:
